References
1a
Ndkala AJ.
Hashemzadeh M.
So RC.
Howell AR.
Org. Lett.
2002,
4:
1719
1b
Tuch A.
Saniere M.
Le Merrer Y.
Depezay JC.
Tetrahedron: Asymmetry
1996,
7:
897
2a
Nakajima N.
Isobe T.
Irisa S.
Ubukata M.
Heterocycles
2003,
59:
107 ; and references cited therein
2b
Gravier-Pelletier C.
Milla M.
Le Merrer Y.
Depezay JC.
Eur. J. Org. Chem.
2001,
3089
3a
Takahata H.
Banba Y.
Sasatani M.
Nemoto H.
Kato A.
Adachi I.
Tetrahedron
2004,
60:
8199
3b
Singh OV.
Han H.
Tetrahedron Lett.
2003,
44:
2387
3c
Lee HK.
Chun JS.
Pak CS.
Tetrahedron
2003,
59:
6445
4a
Baddorey R.
Cativiela C.
Diaz-de-Villegas MD.
Diez R.
Galvez JA.
Eur. J. Org. Chem.
2003,
2268
4b
Merino P.
Franco S.
Merchan FL.
Revuelta J.
Tejero T.
Tetrahedron Lett.
2002,
43:
459
4c
Harms G.
Schaumann E.
Adiwidjaja G.
Synthesis
2001,
577
4d
Khiar N.
Singh K.
Garcia M.
Martin-Lomas M.
Tetrahedron Lett.
1999,
40:
5779
4e
Dequeker E.
Compernolle F.
Toppet S.
Hoornaert G.
Tetrahedron
1995,
51:
5877
5a
Behrens CH.
Sharpless KB.
J. Org. Chem.
1985,
50:
5696
5b
Roush WR.
Adam MA.
J. Org. Chem.
1985,
50:
3752
6
Findeis MA.
Whitesides GM.
J. Org. Chem.
1987,
52:
2838
7
Singh OV.
Han H.
Tetrahedron Lett.
2003,
44:
5289
8a
Greck C.
Drouillat B.
Thomassigny C.
Eur. J. Org. Chem.
2004,
1377
8b
Greck C.
Genêt JP.
Synlett
1997,
741
8c
Genêt JP.
Greck C.
Lavergne D.
Modern Amination Methods
Ricci A.
Wiley-VCH;
Weinheim:
2000.
p.65
9
Kitamura M.
Ohkuma S.
Inoue S.
Sayo N.
Kumabayashi H.
Akutagawa S.
Ohta T.
Tabaya H.
Noyori R.
J. Am. Chem. Soc.
1988,
110:
629
10a
Genêt JP.
Ratovelomanana-Vidal V.
Cano de Andrade MC.
Pfister X.
Guerreiro P.
Lenoir JY.
Tetrahedron Lett.
1995,
36:
4801
10b
Ratovelomanana-Vidal V.
Genêt JP.
Organomet. Chem.
1998,
567:
163
11
Guanti G.
Banfi L.
Narisano E.
Tetrahedron Lett.
1989,
30:
5507
12
Nicolaou KC.
Mitchell HJ.
Fylaktakidou KC.
Rodriguez RM.
Suzuki H.
Chem.-Eur. J.
2000,
6:
3116
13
Fukuyama T.
Laird AA.
Hotchkiss LM.
Tetrahedron Lett.
1985,
26:
6291
14
Characterization of Selected New Compounds:
Compound 8: [α]D
25 -13 (c 0.52, EtOH). 1H NMR (300 MHz, CDCl3): δ = 7.36-7.33 (m, 5 H), 5.43 (d, 1 H, J = 6.4 Hz), 4.75 (d, 1 H, J = 11.7 Hz), 4.62 (d, 1 H, J = 11.7 Hz), 3.92-3.80 (m, 4 H), 3.71-3.63 (m, 2 H), 2.40 (s, 1 H), 1.43 (s, 9 H), 1.08, 1.07 (2 s, 21 H). 13C NMR (50 MHz, CDCl3): δ = 156.1, 138.0, 128.5, 127.9, 127.8, 80.3, 79.4, 72.9, 64.2, 63.1, 52.9, 28.3, 18.0, 11.8. Anal. Calcd for C25H45NO5Si: C, 64.20; H, 9.70; N, 2.99. Found: C, 64.43; H, 9.78; N, 2.85.
Compound 9a: [α]D
25 -12 (c 0.81, EtOH). 1H NMR (300 MHz, CDCl3): δ = 8.01 (m, 2 H), 7.61-7.52 (m, 1 H), 7.44-7.41 (m, 2 H), 7.34-7.28 (m, 5 H), 5.24 (d, 1 H, J = 9.1 Hz), 4.78 (d, 1 H, J = 11.8 Hz), 4.62 (d, 1 H, J = 11.8 Hz), 4.49-4.37 (m, 2 H), 4.34-4.21 (m, 1 H), 3.95 (m, 2 H), 3.72-3.66 (m, 1 H), 1.40 (s, 9 H), 1.09, 1.08 (2 s, 21 H). 13C NMR (75 MHz, CDCl3): δ = 166.4, 155.5, 138.2, 133.5, 132.9, 130.1, 129.7, 128.4, 128.3, 127.9, 127.7, 79.3, 78.9, 72.8, 64.5, 64.2, 50.7, 28.3, 18.0, 11.8. Anal. Calcd for C32H49NO6Si: C, 67.21; H, 8.64; N, 2.45. Found: C, 67.41; H, 8.89; N, 2.41.
Compound 9b: [α]D
25 -1.2 (c 0.50, EtOH). 1H NMR (300 MHz, CDCl3): δ = 7.26 (s, 5 H), 6.83 (s, 4 H), 5.34 (d, 1 H, J = 8.1 Hz), 4.78 (d, 1 H, J = 11.4 Hz), 4.71 (d, 1 H, J = 11.4 Hz), 4.18 (dd, 1 H, J = 9.2, 3.5 Hz), 4.15-4.04 (m, 1 H), 4.00-3.91 (m, 3 H), 3.78 (s, 3 H), 3.76-3.71 (m, 1 H), 1.43 (s, 9 H), 1.10, 1.08 (2 s, 21 H). 13C NMR (75 MHz, CDCl3): δ = 155.5, 154.0, 152.8, 138.5, 128.3, 127.9, 127.5, 115.5, 114.7, 79.3, 78.9, 73.1, 67.5, 65.2, 55.8, 51.0, 28.4, 18.0, 11.9. Anal. Calcd for C32H51NO6Si: C, 66.98; H, 8.96; N, 2.44. Found: C, 66.91; H, 8.84; N, 2.39.